Lindsey B. Taylor, MD

Lindsey Taylor

Assistant Professor

Specialties

  • Breast Medical Oncology

Areas of Expertise

Breast Cancer

Distinctions

Treatment Philosophy

The field of oncology and cancer therapeutics is growing and changing at an immensely fast pace, creating new, promising opportunities for our patients every day.  I am fortunate to specialize in the treatment of patients with breast cancer and classical hematologic conditions at Fox Chase. I find the greatest joy in working to help patients understand their unique diagnoses and options to personalize a care plan that fits them best. I believe providing excellent care requires great communication between the medical team, the patient, and their loved ones, and I work to prioritize this in my practice.

Cancer care is delicate and complex and I feel privileged to be a part of the team at Fox Chase focused on achieving the best possible outcome for each patient we see. 

Clinical Locations

  • Fox Chase Cancer Center
    333 Cottman Avenue
    Philadelphia, PA 19111
    Phone: 888-369-2427

Educational Background

  • Fellowship, Hematology and Oncology, University of Virginia, School of Medicine, Charlottesville, VA, 2022
  • Internship and Residency, Internal Medicine Duke University Health, Durham, NC, 2019
  • M.D., Pennsylvania State University College of Medicine, Hershey, PA, 2016
  • B.S., Biology, Muhlenberg College, PA, 2012

Certifications

  • American Board of Internal Medicine - Internal Medicine
  • American Board of Internal Medicine - Hematology
  • American Board of Internal Medicine - Medical Oncology

Memberships

  • Society for lmmunotherapy of Cancer (SITC), member, 2021-Present
  • American Society of Hematology (ASH), member, 2019-Present
  • American Society of Clinical Oncology (ASCO), member, 2019-Present

Honors & Awards

  • Philadelphia Magazine Top Doctors, 2026

Selected Publications

Courville EL, Shantzer L, Vitzthum von Eckstaedt HC, Mellot H, Keng M, Sen J, Morris A, Williams E, El Chaer F. Variant Acute Promyelocytic Leukemia Presenting Without Auer Rods Highlights the Need for Correlation with Cytogenetic Data in Leukemia Diagnosis. Lab Med. 2022 Jan 6;53(1):95-99. doi: 10.1093/labmed/lmab051. PMID: 34268555.

McNamara MA, Oyekunle T, Chin BB, Oldan J, Anand A, Ritz M, Shantzer L, Anand M, Armstrong AJ, George DJ. Patterns of response and progression in bone and soft tissue during and after treatment with radium-223 for metastatic castrate-resistant prostate cancer. Prostate. 2019 Jul;79(10):1106-1116. doi: 10.1002/pros.23822. Epub 2019 May 2. PMID: 31045266.

Jacobs MT, Mohindra NA, Shantzer L, Chen IL, Phull H, Mitchell W, Raymond VM, Banks KC, Nagy RJ, Lanman RB, Christensen J, Patel JD, Clarke J, Patel SP. Use of Low-Frequency Driver Mutations Detected by Cell-Free Circulating Tumor DNA to Guide Targeted Therapy in Non-Small-Cell Lung Cancer: A Multicenter Case Series. JCO Precis Oncol. 2018 Nov;2:1-10. doi: 10.1200/PO.17.00318. PMID: 35135131.

Shantzer L, Berger K, Pu JJ. Primary myelofibrosis and its targeted therapy. Ann Hematol. 2017 Apr;96(4):531-535. doi: 10.1007/s00277-016-2785-9. Epub 2016 Aug 19. PMID: 27539616.

Additional Publications

NCBI

Related Articles